Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner

Abstract Short‐chain fatty acids (SCFAs) are the end products of the fermentation of dietary fibers by the intestinal microbiota and reported to exert positive effects on host physiology. Acetate is the most abundant SCFA in humans and is shown to improve acute kidney injury in a mouse model of isch...

Full description

Bibliographic Details
Main Authors: Chiaki Kawabata, Yosuke Hirakawa, Reiko Inagi, Masaomi Nangaku
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.15774
_version_ 1797771089211817984
author Chiaki Kawabata
Yosuke Hirakawa
Reiko Inagi
Masaomi Nangaku
author_facet Chiaki Kawabata
Yosuke Hirakawa
Reiko Inagi
Masaomi Nangaku
author_sort Chiaki Kawabata
collection DOAJ
description Abstract Short‐chain fatty acids (SCFAs) are the end products of the fermentation of dietary fibers by the intestinal microbiota and reported to exert positive effects on host physiology. Acetate is the most abundant SCFA in humans and is shown to improve acute kidney injury in a mouse model of ischemia–reperfusion injury. However, how SCFAs protect the kidney and whether SCFAs have a renoprotective effect in chronic kidney disease (CKD) models remain to be elucidated. We investigated whether acetate and other SCFAs could attenuate the kidney damage. In in vitro experiments, cell viability of acetate‐treated human kidney 2 (HK‐2) cells was significantly higher than that of vehicle‐treated in an oxidative stress model, and acetate reduced cellular reactive oxygen species (ROS) production. In mitochondrial analysis, the MitoSOX‐positive cell proportion decreased, and transcription of dynamin‐1‐like protein gene, a fission gene, was decreased by acetate treatment. In in vivo experiments in mice, acetate treatment significantly ameliorated fibrosis induced by unilateral ureteral obstruction, and the oxidative stress marker phosphorylated histone H2AX (γH2AX) was also reduced. Further, acetate treatment ameliorated dysmorphic mitochondria in the proximal tubules, and ROS and mitochondrial analyses suggested that acetate improved mitochondrial damage. Our findings indicate a renoprotective effect of acetate in CKD.
first_indexed 2024-03-12T21:32:28Z
format Article
id doaj.art-54c443327d4646d0ae04a6c4158dc0ab
institution Directory Open Access Journal
issn 2051-817X
language English
last_indexed 2024-03-12T21:32:28Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Physiological Reports
spelling doaj.art-54c443327d4646d0ae04a6c4158dc0ab2023-07-27T17:26:30ZengWileyPhysiological Reports2051-817X2023-07-011114n/an/a10.14814/phy2.15774Acetate attenuates kidney fibrosis in an oxidative stress‐dependent mannerChiaki Kawabata0Yosuke Hirakawa1Reiko Inagi2Masaomi Nangaku3Division of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo JapanDivision of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo JapanDivision of Chronic Kidney Disease Pathophysiology The University of Tokyo Graduate School of Medicine Tokyo JapanDivision of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo JapanAbstract Short‐chain fatty acids (SCFAs) are the end products of the fermentation of dietary fibers by the intestinal microbiota and reported to exert positive effects on host physiology. Acetate is the most abundant SCFA in humans and is shown to improve acute kidney injury in a mouse model of ischemia–reperfusion injury. However, how SCFAs protect the kidney and whether SCFAs have a renoprotective effect in chronic kidney disease (CKD) models remain to be elucidated. We investigated whether acetate and other SCFAs could attenuate the kidney damage. In in vitro experiments, cell viability of acetate‐treated human kidney 2 (HK‐2) cells was significantly higher than that of vehicle‐treated in an oxidative stress model, and acetate reduced cellular reactive oxygen species (ROS) production. In mitochondrial analysis, the MitoSOX‐positive cell proportion decreased, and transcription of dynamin‐1‐like protein gene, a fission gene, was decreased by acetate treatment. In in vivo experiments in mice, acetate treatment significantly ameliorated fibrosis induced by unilateral ureteral obstruction, and the oxidative stress marker phosphorylated histone H2AX (γH2AX) was also reduced. Further, acetate treatment ameliorated dysmorphic mitochondria in the proximal tubules, and ROS and mitochondrial analyses suggested that acetate improved mitochondrial damage. Our findings indicate a renoprotective effect of acetate in CKD.https://doi.org/10.14814/phy2.15774acetatechronic kidney diseasemitochondriareactive oxygen speciesshort‐chain fatty acid
spellingShingle Chiaki Kawabata
Yosuke Hirakawa
Reiko Inagi
Masaomi Nangaku
Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
Physiological Reports
acetate
chronic kidney disease
mitochondria
reactive oxygen species
short‐chain fatty acid
title Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
title_full Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
title_fullStr Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
title_full_unstemmed Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
title_short Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
title_sort acetate attenuates kidney fibrosis in an oxidative stress dependent manner
topic acetate
chronic kidney disease
mitochondria
reactive oxygen species
short‐chain fatty acid
url https://doi.org/10.14814/phy2.15774
work_keys_str_mv AT chiakikawabata acetateattenuateskidneyfibrosisinanoxidativestressdependentmanner
AT yosukehirakawa acetateattenuateskidneyfibrosisinanoxidativestressdependentmanner
AT reikoinagi acetateattenuateskidneyfibrosisinanoxidativestressdependentmanner
AT masaominangaku acetateattenuateskidneyfibrosisinanoxidativestressdependentmanner